반응식
CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(C(C)C)C(C)C)C.[K+].[CH3:35][C:36]1[O:40][C:39]([C:41]([O-:43])=O)=[N:38][N:37]=1.[F:44][C:45]1[CH:50]=[CH:49][C:48]([N:51]2[C:59]3[C:54](=[CH:55][C:56]([O:60][C@@H:61]([C:65]4[CH:70]=[CH:69][CH:68]=[CH:67][CH:66]=4)[C@H:62]([NH2:64])[CH3:63])=[CH:57][CH:58]=3)[CH:53]=[N:52]2)=[CH:47][CH:46]=1>CN(C=O)C.ClCCl>[F:44][C:45]1[CH:46]=[CH:47][C:48]([N:51]2[C:59]3[C:54](=[CH:55][C:56]([O:60][C@H:61]([C:65]4[CH:66]=[CH:67][CH:68]=[CH:69][CH:70]=4)[C@@H:62]([NH:64][C:41]([C:39]4[O:40][C:36]([CH3:35])=[N:37][N:38]=4)=[O:43])[CH3:63])=[CH:57][CH:58]=3)[CH:53]=[N:52]2)=[CH:49][CH:50]=1참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
To a stirred solution of HATU (630 mg, 1.66 mmol) in DMF (1 ml) was added ethyldiisopropylamine (570 μl, 3.3 mmol), followed by 5-methyl-[1,3,4]oxadiazol carboxylic acid potassium salt (138 mg, 830 μmol) and stirred for 20 min. Then (1S,2R)-1-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-phenylpropan-2-amine (300 mg, 830 mmol) in DMF (1 ml) was added to the brown/red solution and the stirring was continued for 24 h at r.t. The mixture was diluted by dichloromethane and filtrated through a path of silica gel. Solvent was removed under reduced pressure, and the residue was purified by preparative TLC on silica gel (hexane/acetone 50%). Yield 82 mg (21%).
후처리
- waitthe stirring was continued for 24 h at r.t
- filtrationfiltrated through a path of silica gel
- customSolvent was removed under reduced pressure
- customthe residue was purified by preparative TLC on silica gel (hexane/acetone 50%)
출처 및 근거
- ORD 기록
- ord-781086b4514f44cf9072f757beb9763e
- 출처 데이터셋
- uspto-grants-2012_03
- 특허 번호
- US08143290B2
연결된 노트
불러오는 중…